Galderma publishes its 2024 Annual Report and the invitation to its first Annual General Meeting
Ad hoc announcement pursuant to Art. 53 LR
Zug, Switzerland, March 21, 2025 – Galderma Group AG (SIX: GALD), the pure-play dermatology category leader, today published its 2024 Annual Report along with the invitation to its first Annual General Meeting which will be held on April 23, 2025.
Galderma’s 2024 Annual Report, the 2024 Finance Report and the invitation to the Annual General Meeting are available on Galderma’s Investor Relations website at https://investors.galderma.com/.
About Galderma
Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.
For further information:
|
Media Christian Marcoux, M.Sc. Chief Communications Officer christian.marcoux@galderma.com +41 76 315 26 50 |
Investors
Emil Ivanov Head of Strategy, Investor Relations and ESG +41 21 642 78 12 |
|
Sébastien Cros Corporate Communications Director +41 79 529 59 85 |
Jessica Cohen Investor Relations and Strategy Director +41 21 642 76 43 |